Artemisinine resistence of P. falciparum malaria in Suriname

The emerging resistance to artemisinin derivatives that has been reported in South-East Asia led us to assess the efficacy of artemether-lumefantrine as the first line therapy for uncomplicated Plasmodium falciparum infections in Suriname. The decreasing number of malaria cases in Suriname, which are currently limited to migrating populations and gold miners, precludes any conclusions on artemether efficacy because adequate numbers of patients are difficult to obtain. Therefore, a parasitaemia  study is conducted to detect the emergence of resistance to artemether.